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s is an
/licensPURPOSE: To use a well-established organ culture model to investigate the effects of corneal
stromal stem cells on the optical and biomechanical properties of corneal wounds after laser in
situ keratomileusis (LASIK)–like flap creation.
SETTING: School of Optometry and Vision Sciences, Cardiff University, Cardiff, Wales, United
Kingdom.
DESIGN: Experimental study.
METHODS: The LASIK-like flaps were produced in sheep corneas. The flap beds were treated with
corneal stromal stem cells and were then replaced and allowed to heal for different periods of up to
3 weeks in organ culture. The optical transmission of the cornea, the force required to detach the
flap, and the presence of myofibroblasts near the flap bed were measured.
RESULTS: Corneal stromal stem cell–treated flap beds were statistically significantly more trans-
parent after 3 weeks in culture than the untreated controls. At 3 weeks, the mean force necessary
to detach the flap was more than twice the force required for the respective control samples.
Concurrently, there were 44% activated cells immediately below the flap margin of the controls
compared with 29% in the same region of the corneal stromal stem cell–treated flaps.
CONCLUSIONS: In this system, the presence of corneal stromal stem cells at the wound margin
significantly increased the adherence of LASIK-like flaps while maintaining corneal transparency.
It is postulated that this is achieved by the deposition of extracellular connective tissue similar to
that found in the normal cornea and by the paucity of activated keratocytes (myofibroblasts),
which are known to scatter a significant amount of the incident light.
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creativecommons.org/licenses/by/4.0/).Clinical procedures that improve the refractive state of
the eye are increasingly used to improve vision. Laser
in situ keratomileusis (LASIK) is the most common
elective operation, with more than 35 million proce-
dures performed worldwide by 2010.1 In addition,
there are corneal injuries that account for a small but
significant fraction of ocular trauma and that require
immediate assistance; these include burns (chemical
and thermal) and subepithelial abrasions.2,3 In gen-
eral, the outcome of surgical or accidental corneale Authors. Published by Elsevier Inc. on behalf of ASCRS and ESCRS.
open access article under the CC BY license (http://creativecommons.
es/by/4.0/).injury is a reduction in biomechanical strength and
transparency, with incomplete adherence of the
affected tissue after extracellular matrix (ECM) remod-
eling. These changes depend on the type of injury, and
hence on the type of connective tissue, and other mate-
rials deposited as well as on changes to the refractive
index of corneal cells after activation with inflamma-
tory growth factors and cytokines.4,5
The specialized order of the cornea's stromal
collagen governs the biomechanical and transparenthttp://dx.doi.org/10.1016/j.jcrs.2015.09.023
0886-3350
303LABORATORY SCIENCE: HEALING OF LASIK-LIKE FLAPSproperties of the tissue.6 When an injury is incurred,
this precise collagenous arrangement is altered. The
initial objective of the wound-healing cascade is to
rapidly barricade the wound and prevent the invasion
of foreign bodies or infections.7 The impaired epithe-
lium releases cytokines, causing swelling and inflam-
mation that can lead to changes in corneal hydration.
Activated corneal keratocytes heal the wound by pro-
ducing collagen and other ECM materials; however,
this can lead to a reduction in transparency. Further-
more, fibroblasts (activated keratocytes) and myofi-
broblasts (more highly activated fibroblasts that are
capable of contraction) show significantly reduced
levels of crystallin proteins,4,8 and this has been found
to correlate with a marked increase in light scattering
or “corneal haze.”9 In rabbits, it takes at least 6 months
for the remodeling to stop and the cells to undergo
apoptosis or return to homeostasis.10
In procedures such as LASIK in which a hinged flap
is created in the stromal bed,11 limited wound healing
occurs by means of an epithelial plug around the cut
margins and the deposition of minimal fibrotic mate-
rial along the bed of the wound.12 Laser in situ kerato-
mileusis flaps are known to be inadequate healers,
retaining only 2% to 28% of their tensile strength for
more than a decade after surgery.13 Therefore, ectasiaSubmitted: April 15, 2015.
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J CATARACT REFRACT SURG - Vas well as partial and complete flap detachments are
common long-term postoperative challenges.14–17
The fragility of the flap margin also means that the
interface is prone to opening, and this introduces the
risk for exposing the patient to infection from opportu-
nistic organisms such as viruses and bacteria. For these
reasons, increasing flap adhesive strength while main-
taining transparency is a clinical goal. In previous
studies, corneal fibroblasts, crosslinking, and
fibrinogen-based glues have been used in an attempt
to increase flap strength in in vitro models.18,19
New work has involved a range of topical, engi-
neered, and cellular treatments to increase wound
healing and decrease scar formation. Recently, stem
cells isolated from adult human corneal stroma were
earmarked as having the potential as a stem cell–based
treatment for corneal opacity.20 These cells, referred to
as corneal stromal stem cells, have been shown to have
the ability to remodel stromal ECM into a tissue essen-
tially indistinguishable from that of wild-type matrix,
and they maintain the ability to produce this ECM
even after extensive expansion in vitro.20,21 In the cur-
rent study, we examined the ability of these cells to
improve corneal wound healing and hence increase
the adherence strength of LASIK-like flaps while
maintaining clarity in an ovine corneal model.
MATERIALS AND METHODSOrgan Culture and Cell TreatmentNinety whole ovine corneas were obtained from a local
abattoir and surgically wounded by introducing a corneal
flap of midstromal depth using a microkeratome (Hansa-
tome, Bausch & Lomb). Only healthy eyes with clear/trans-
parent corneas were selected for wounding. The stromal bed
beneath the flap was not ablated as performed in traditional
LASIK procedures; however, the wounds are referred to
as LASIK-like. The 90 wounded eyes were divided into
2 groups; that is, wounded controls and those to be treated
with human corneal stromal stem cells.
Human corneal stromal stem cells were provided by the
University of Pittsburgh, School of Medicine, Pittsburgh,
Pennsylvania, USA. They were shipped on ice, and on
arrival theywere incubated overnight at 37C in a 5% carbon
dioxide (CO2) incubator to ensure cell attachment. Theywere
then washed with sterile phosphate-buffered saline (PBS)
before being treated with trypsin (TrypLE, Life Technolo-
gies) for 10minutes at 37C. Last, the cells were gently centri-
fuged at 4C and resuspended inmedium (Medium 199, Life
Technologies Corp.) at 6.5 cells/mL  104 cells/mL.
Forty-five corneas were treated with human corneal stro-
mal stem cells. The LASIK-like flaps were raised using a ster-
ile pipette tip, and 10 mL of the 6.5 cells/mL  104 cells/mL
suspension was carefully applied beneath each flap. The flap
was then repositioned using a pipette tip. The corneas were
dissected out, leaving a scleral rim of approximately 2.0 mm,
and cultured as previously described18,22,23 for up to 3weeks.
A preparation of agar–gelatin support gel was introduced
into the posterior endothelial cavity of each cornea to the
level of the limbal ring, and each cornea was inverted intoOL 42, FEBRUARY 2016
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containing amphotericin B (Fungizone) and antibiotics was
added to each dish up to the limbal area to preserve the cor-
neas during the culture period. The dishes were then trans-
ferred to a sterile CO2 incubator to incubate for the
required culture time period. Two hundred microliters of
medium were applied to each cornea twice every 24 hours
throughout the duration of the experiment to keep the
corneal surface moist and to prevent bacterial or fungal
infection. The culture medium in each dish was replaced
with fresh medium every 4 days during the culture period.
Forty-five corneas acted as wounded controls without the
application of cells and were processed for culture as above.
The corneas were removed from culture at 1-week, 2-week,
and 3-week timepoints (14 treated and 14 control corneas
at 1 and 2 weeks and 17 treated and 17 control corneas at
3 weeks). Because of the nature of the organ culture process,
not all corneas introduced into culture survived for experi-
mentation. After the culture period, the corneas were
immersed in dextran 8% solution (in medium) at 37C over-
night to restore homeostasis before assessment of transpar-
ency, flap adherence, and mechanical strength.Evaluation of Corneal TransparencyTransparency was evaluated by taking spectrophoto-
metric measurements across the visible spectrum. A spec-
trophotometer (SP8-100 UV/VIS, Pye Unicam Ltd.) was
used to measure the transparency of the central flap region.
To minimize possible effects in light transmission caused by
differences in stromal hydration and thickness, central
corneal pachymetry (Pachmate DGH55, DGH Technology,
Inc.) was performed on all samples. Only corneas with a
thickness of less than 850 mm were included. The corneas
were rinsed in PBS to remove the dextran and introduced
to a purpose-built chamber with 2 flat machine-polished
glass windows. The cornea's natural curvature was main-
tained by clamping the scleral rim in the sample holder
and injecting silicone oil (200/5cS, Dow Corning) behind
it. Corneas that were too small to allow adequate clamping
were excluded and retained for mechanical strength or
immunohistochemical assessment. To maintain a uniform
refractive index and limit light scatter, silicone oil was
also injected into the front chamber of the holder. The sam-
ple holder was then positioned into the spectrophotometer
in such a way that light passed through the center of the
flap in the anterior–posterior direction. The 1.0 mm beam
of white light was passed through a series of filters to pro-
duce monochromatic light. A transmission spectrum was
then measured first for the chamber filled with silicone oil
to act as the blank and then for each cornea at 10 nm inter-
vals in the range of 400 to 700 nm. The measurements were
repeated 3 times for each sample. Further readings were
taken toward the periphery of the tissue to ensure the reli-
ability of the transparency readings, and the transparency
decreased with the greater thickness of the peripheral tis-
sue. The values were normalized by dividing the blank
values into the respective sample values and multiplying
by 100 to obtain the percentage transmittance of light
across the wavelengths.Assessment of Flap Mechanical AdherenceThe extent of flap adhesion in both corneal stromal stem
cell–treated and untreated samples was measured using a
vertical extensometer set to perform a “pull to break” testJ CATARACT REFRACT SURG - V(Lloyd Instruments Ltd.). Cardboard strips of dimensions
0.25 cm  2.5 cm were cut and adhered using cyanoacrylate
adhesive to the middle of the anterior side and posterior side
of each cornea. The strips were clamped opposite each other
so that the force would pull along the y-axis. The force that
was required to separate the flap from the underlying stro-
mal bed (referred to as the first breakpoint) was recorded us-
ing the Nexygen 4.1 software package (Lloyd Instruments
Ltd.).ImmunohistochemistryCell phenotype of activated fibroblasts during the heal-
ing process was examined by anti-a-smooth muscle actin
(a-sma) immunostaining at each of the 3 culture timepoints.
The corneal samples were stored in paraformaldehyde 4%
(at 4C) for 24 hours and then wax embedded. Wax sections
(10 mm thick) cut with a microtome (Leica Microsystems
GmbH)weremounted onHistabond adhesive slides (Utech
Products, Inc.) and left overnight to adhere. As a conse-
quence, tissue sections were dewaxed using xylene and re-
hydrated in decreasing concentrations of ethanol. The
sections were then treated with goat serum (Sigma-Aldrich
Co.) in PBS (1:4 vol/vol) for 30 minutes at room tempera-
ture. The primary antibody, anti-a-sma mouse monoclonal
antibody (Sigma-Aldrich Co.), in PBS–0.2% bovine serum
albumin (1/200) was applied to the sections and left to incu-
bate overnight at 4C. The following day, the sections were
incubated with the secondary antibody Alexa Fluor 488
goat anti-mouse immunoglobulin G (Invitrogen Corp.)
(1/1000) in PBS along with 3 mL of Hoescht 33342 (Invitro-
gen Corp.) for 2 hours in the dark at room temperature and
mounted with Hydromount (National Diagnostics).
Finally, all slides were imaged using a Leica 6000 fluores-
cent microscope with 40,6-diamidino-2-phenylindole dihy-
drochloride (blue) and fluorescein isothiocyanate (green)
filter sets for detection of Hoescht 33342-bound and Alexa
Fluor 488-bound a-sma, respectively, at20 magnification.
Average total cell counts were obtained by measuring the
total number of cells in a set field of view and were aver-
aged over 6 fields of view per section (6 tissue sections
per sample). The field of view was a region of the image
taken at 20 magnification of a 10 mm thick section
(nZ 3 treated and nZ 3 control corneas at each timepoint).Statistical AnalysisFor direct comparisons within and between timepoints,
the normalized transmitted intensity measurements in the
middle of the visible spectrum (550 nm) and the breakpoint
data were examined statistically by t tests or analysis of vari-
ance (ANOVA) and post hoc least-significant-difference
testing using Statistica software (version 7.1, Statsoft, Inc.).
RESULTSTransparencyThe transparency of the samples could be measured
at all organ culture time periods, verifying the integ-
rity of the culture technique and its capacity to limit
corneal swelling (Figure 1). At 0 weeks, all corneas
were visually clear; however some, in particular in
the control group, became cloudier with incubation
time. Spectrophotometry showed that the differenceOL 42, FEBRUARY 2016
Figure 1. Transparency results at 1, 2, and 3weeks for corneal stromal stem cell–treated samples (pink) andwounded control samples (blue) show
that the transparency of the corneal stromal stem cell–treated corneas at 550 nm was significantly higher than that of the control corneas by
3 weeks (*Z statistically significant, unpaired t tests [at 550 nm]; CSSCZ corneal stromal stem cell).
305LABORATORY SCIENCE: HEALING OF LASIK-LIKE FLAPSbetween the control group and the treated group
became statistically significant only after 3 weeks.
The thickness of the control samples at 2 and 3 weeks
was on average greater than that of the treated sam-
ples at these timepoints and the 1-week control sam-
ples; however, this increase in thickness was not
significant (Table 1). Therefore, it can be said that the
differences in transparency observed between control
corneas and treated corneas were a direct result of
the corneal stromal stem cell application as opposed
to being attributed to the culture model.Mechanical Adhesion of the FlapThe mean force required to detach the flap at the
1-week timepoint appeared to be elevated in
response to cell treatment compared with controls;
however, this was not significant with the sample
numbers used (P O .05, ANOVA with Tukey post
hoc least-significant-difference testing) (Figure 2).
The mean flap detachment force decreased in control
samples at 2 weeks compared with 1 week and then
increased again after 3 weeks; however, statisticalTable 1. Mean corneal thickness measurements for control and
treated samples at each culture timepoint.
Time
Mean Corneal Thickness (mm)G SD
Control CSSC Treated
1 week 718G 10.3 737G 87.5
2 weeks 728G 35.1 705G 54.6
3 weeks 761G 71.1 714G 63.4
CSSCZ corneal stromal stem cells
There were no significant differences in thickness between groups or
across timepoints (all P! .05, unpaired t tests)
J CATARACT REFRACT SURG - Vanalysis showed no significant differences in mean
force values between the 3 timepoints (P O .05,
1-way ANOVA with Tukey post hoc tests). The flap
strength of the corneal stromal stem cell–treated sam-
ples gradually increased as the duration of the cul-
ture increased; however, the difference between
control samples and treated samples became signifi-
cant only after 3 weeks in culture. At the 3-week
timepoint, the mean force necessary to detach the
flap was more than twice the force required for the
respective control samples.Figure 2.Mechanical assessment of control and corneal stromal stem
cell–treated flap adherence. The mean flap detachment force was
significantly greater in the corneal stromal stem cell–treated corneas
than in the controls at week 2 (PZ .044). By the third week culture
point, the mean force was more than twice the level of the control
corneas (P Z .038) (* Z statistically significant, unpaired t tests;
CSSCZ corneal stromal stem cell).
OL 42, FEBRUARY 2016
306 LABORATORY SCIENCE: HEALING OF LASIK-LIKE FLAPSMyofibroblast ExpressionImmunohistochemistry indicated amarked increase
in the total number of cells in the control corneas and
cell-treated corneas between 1 week and 2 weeks,
with treated corneas having larger cell counts than
control corneas at both timepoints. After 3 weeks in
culture, there was a detectable decrease in the stromal
cell number in the keratectomy wound region in both
control corneas and treated corneas. Using the cell
count at 1 week as a baseline, treated tissue cell
numbers diminished to below this value, whereas
control tissue cell numbers, despite a pronounced
decrease after 3 weeks, remained elevated.
Figure 3 shows examples of a-sma immunolabeling
detected in control samples and treated samples at
each culture timepoint. The extent of a-sma staining
in control tissue and corneal stromal stem cell–treated
tissue was comparable and was largely restricted toJ CATARACT REFRACT SURG - Vthe stromal flap bed. After 2 weeks and 3 weeks in cul-
ture, the control samples had an increase in a-sma
staining along the flap bed and deeper into the tissue
below the flap bed (Table 2). In the corresponding re-
gions of corneal stromal stem cell–treated tissue, the
computed a-sma activation at these timepoints was
lower. These a-sma–expressing cells were predomi-
nately located deeper in the tissue below the flap bed
(Figure 3, D and F). The mean percentage activation
was consistently lower in treated samples than in con-
trol samples, without substantial increases, and this
correlated with the invariable transparency observed
through the culture periods in these corneas.DISCUSSION
In this study, the organ culturemodel as outlined byMi
et al.,18 Foreman et al.,22 andKamma-Lorger et al.23wasFigure 3. Immunohistochemistry results for
a-sma expression in LASIK-like flap beds of
control corneas (left) and corneal stromal
stem cell–treated corneas (right) after 1 week
(A and B), 2 weeks (C and D), and 3 weeks
(E and F) in culture. Treated corneas showed
fewer a-sma positive cells than control cor-
neas at all 3 timepoints (yellow arrows).
(greenZ a-sma; blueZ Hoechst cell nuclei).
Thewhite arrows indicate the flap bed (original
magnification20; calibration barsZ 50 mm).
OL 42, FEBRUARY 2016
Table 2. Mean total cell count and the percentage of activated








Control 176G 17.6 24
CSSC treated 204G 21.3 19
2 weeks
Control 223G 18.1 48
CSSC treated 227G 17.1 30
3 weeks
Control 191G 14.8 44
CSSC treated 186G 12.9 29
CSSCZ corneal stromal stem cells
307LABORATORY SCIENCE: HEALING OF LASIK-LIKE FLAPSused to assess LASIK-like wound healing after the
application of stem cells from the human corneal
stroma. This organ culture method is favored over sim-
ple cell culture for observing wound healing because of
its capacity to imitate corneal structure, cellular interac-
tions, and wound healing with accuracy.24
The increase in flap strength measured for corneal
stromal stem cell–treated corneas can be attributed
to the demonstrated potential for corneal stromal
stem cells to produce and organize abundant con-
nective tissue including collagens type I, V, and VI
and keratan sulfate proteoglycans that are located
only in the cornea.25–27 When corneal stromal stem
cells are introduced into corneas in vivo, they also
adopt a keratocyte phenotype and secrete human
stromal matrix components, replacing disorganized
or scar tissue with organized stromal tissue indistin-
guishable from that of native cornea.20,21 Based on
these previous studies, we speculate that in our cur-
rent experiments, remodeling of the connective tis-
sue on either side of the keratectomy wound by
corneal stromal stem cells was in progress, leading
to the increased wound strength at 3 weeks and
eventually full healing of the flap to the rest of the
cornea. Larger in vitro and in vivo studies per-
formed for extended periods will be required to
confirm this hypothesis. Tests at the edge and cen-
tral regions of the flap will also be necessary.
By 3 weeks, the transparency of corneal stromal
stem cell–treated corneas was significantly higher
than that of untreated control corneas. At this time-
point, there was no significant difference in corneal
thickness between control samples and the treated
samples; however, at this time, the corneal stromal
stem cells begin to produce abundant corneal ECM.27
Tissue secreted by corneal stromal stem cells is distinct
from that produced in similar conditions by cornealJ CATARACT REFRACT SURG - Vfibroblasts,28 cells that typically populate corneal
wounds. Fibroblasts are less abundant than myofibro-
blasts in the wound; however, both secrete matrix
components associated with opaque scar tissue.29,30
The reduction in myofibroblasts observed in the
corneal stromal stem cell–treated corneas argues
that, in addition to secreting native corneal matrix,
corneal stromal stem cells suppress the number of cells
in the region that produce scar tissue.
Human corneal stromal stem cells are located sub-
adjacent to the basement membrane, near the limbal
epithelial stem cells.31 Corneal stromal stem cells
might represent the mesenchymal “niche cells” in
this region that help maintain the stem/progenitor
character of the epithelial stem cells in vivo.21,32
Although data have not demonstrated an active
role of these cells in stromal homeostasis, results in
previous studies20,21 suggest that the default lineage
of corneal stromal stem cells is the keratocyte and
that introducing them into the stroma initiates this
transformation. In damaged stroma, however, these
studies showed that corneal stromal stem cells do
not simply replace missing ECM but appear to
initiate regeneration of stromal tissue by the cells of
the host cornea. The ability to induce tissue regener-
ation is now recognized for mesenchymal stem cells
acting on a wide variety of tissues in addition to
cornea.33–38 This process is clearly distinct from
wound healing and although it exhibits aspects of
embryonic development, it does not exactly recapitu-
late that process.39
The regenerative potential of stem cells might be
tied to their immune-modulatory function. Such
cells secrete several factors that suppress activation
of neutrophils, T-cells, and B-cells but also mediate
the phenotype of tissue-resident dendritic cells and
macrophages from proinflammatory to regenerative
phenotypes.40 Exploration of these mechanisms is a
matter of active current research; however, defini-
tive molecular mechanisms linking tissue regenera-
tion and immune modulation are speculative at
this point.
Understanding the regenerative potential and
immunosuppression afforded by corneal stromal
stem cells will strengthen the results in this study
and support the idea that the application of human
corneal stromal stem cells presents a promising
approach for improving the clarity of the cornea
during wound healing and also for increasing the
adherence strength of LASIK corneal flaps. A recent
study36 showed that such a treatment might even be
performed using autologous corneal stromal stem
cells. Such an approach would appear to provide
a new biological therapy with a high degree of
safety.OL 42, FEBRUARY 2016
308 LABORATORY SCIENCE: HEALING OF LASIK-LIKE FLAPSWHAT WAS KNOWN
 Laser in situ keratomileusis flaps never heal completely.
Only an epithelial plug around the cut edge and what
has been termed primitive fibrotic tissue at the flap bed
occur.
 Previous attempts to produce better flap adherence
resulted in loss of corneal transparency. Thus far, no
treatment has been shown to preserve transparency while
increasing flap adherence.WHAT THIS PAPER ADDS
 Corneal stromal stem cells applied at the LASIK flap
margin have the potential to increase flap adherence
while retaining corneal transparency.REFERENCES
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